Selenite (Sodium) / Risk Cancer Research Results

SSE, Selenite (Sodium): Click to Expand ⟱

Features:

Sodium Selenite - is inorganic selenium in the selenite oxidation state (Se⁴⁺)
Sodium selenite is produced industrially from selenium metal, which itself is obtained as a by-product of copper refining.

Mechanistic distinction from Selenium:
-Selenite reacts with GSH → GS–Se–SG intermediates
-Generates superoxide, H₂O₂
-Exploits cancer cells’ elevated basal oxidative stress
-Normal cells neutralize it more effectively (higher redox reserve)

Both the uptake and processing of selenium has recently shown to be upregulated in subsets of cancer cells
 due to their increased expression of xCT transporter
The more a tumor depends on xCT, the more toxic selenite becomes. High xCT Also Increases SSE Toxicity. High xCT increases intracellular thiols, which increases SSE chemical trapping, redox cycling, and cytotoxic impact.

Sodium selenite might protect against toxicity of AgNPs. also here

SSE and cancer

Rank	Pathway / Target Axis	Direction	Primary Effect	Notes / Cancer Relevance	Ref
1	Redox cycling with thiols (superoxide generation)	↑ O2•− / ↑ ROS	Acute oxidative stress	Defines sodium selenite anticancer mechanism in many models: early superoxide rise precedes mitochondrial apoptotic events	(ref)
2	Glutathione buffering (GSH pool)	↓ GSH	Loss of redox buffering	Work in hepatoma models demonstrates GSH’s key role in selenite-driven oxidative stress and apoptosis	(ref)
3	Mitochondrial integrity (ΔΨm)	↓ ΔΨm	Mitochondrial dysfunction	Sequential mechanism shown: superoxide rise → mitochondrial depolarization	(ref)
4	Intrinsic apoptosis (cytochrome c → Caspase-9/3)	↑ cytochrome c release / ↑ Caspase-9/3	Programmed cell death	Same sequential model shows cytochrome c release followed by caspase-9 and caspase-3 activation	(ref)
5	ER stress / UPR (PERK → eIF2α → ATF4)	↑ PERK/eIF2α/ATF4	Proteotoxic stress signaling	ER-stress module is shown as a core driver in selenite-induced autophagy→apoptosis progression	(ref)
6	Stress MAPK (p38) as switch control	↑ p38 activation	Signal switching (autophagy → apoptosis)	Mechanistic evidence for p38 participating in the selenite-driven transition toward apoptosis	(ref)
7	p53 activation (stress response)	↑ p53 phosphorylation (Ser15)	Facilitates apoptosis programs	NB4 leukemia model: selenite induces p53 Ser15 phosphorylation via p38/ERK in the autophagy–apoptosis switch context	(ref)
8	DNA damage response (ATM-dependent signaling)	↑ ATM-dependent DDR	Checkpoint activation & death signaling	Selenium compounds (including selenite contexts) activate ATM-dependent DNA damage response signaling in colorectal cancer models	(ref)
9	PI3K–AKT axis linked to autophagy/apoptosis balance	↓ PI3K/Akt (functional axis) / ↓ protective autophagy	Apoptosis sensitization	NB4 leukemia: sodium selenite increases apoptosis by autophagy inhibition through PI3K/Akt	(ref)
10	NF-κB signaling	↓ NF-κB	Reduced anti-apoptotic transcription	Mechanistic study: sodium selenite induces ROS-mediated inhibition of NF-κB with downstream shift toward apoptosis	(ref)
11	Angiogenesis signaling (VEGF)	↓ VEGF expression	Reduced vascular support signals	Prostate cancer PC3 model: sodium selenite inhibits expression of VEGF (and related inflammatory/pro-growth factors) in the tested context	(ref)
12	Ferroptosis (iron-dependent oxidative death)	↑ ferroptosis	Non-apoptotic oxidative death modality	Paper explicitly reports sodium selenite as an inducer of ferroptosis across multiple human cancer cell types	(ref)

Table to compare Sodium Selenite to SeNPs
-Sodium selenite → chemical oxidant (thiol attack → ROS shock).
-SeNPs → engineered redox stressor (signaling-level control, broader window).
-Selenomethionine / Se-yeast → redox buffer & selenium storage form (often protective to cancer cells, especially when oxidative stress is a therapeutic goal).

Dimension	Sodium Selenite (Na2SeO3)	Selenium Nanoparticles (SeNPs)	Selenomethionine / Se-Yeast
Primary mechanistic class	Direct redox-disrupting agent	Controlled redox modulator / signaling perturbator	Nutritional selenium reservoir / selenoprotein precursor
Initial molecular interaction	Rapid reaction with cellular thiols (GSH, Trx, protein –SH)	Cellular uptake → gradual selenium release or surface redox effects	Nonspecific incorporation into proteins in place of methionine
ROS generation	↑↑ acute, non-buffered ROS burst	↑ mild–moderate, sustained ROS	↓ or ↔ (antioxidant bias)
Glutathione (GSH) system	↓↓ GSH depletion	↔ or mild ↓ (context-dependent)	↑ GSH recycling via GPX support
Redox selectivity (cancer vs normal)	Limited; toxicity threshold close to efficacy	Improved tumor selectivity window	Poor for cancer killing; favors normal-cell protection
Mitochondrial integrity (ΔΨm)	↓↓ rapid depolarization	↓ gradual, dose-dependent disruption	↔ or ↑ mitochondrial protection
Dominant cell-death pathways	Intrinsic apoptosis ± necrosis (high dose)	Apoptosis ± ferroptosis ± autophagy-related death	None (cytoprotective)
ER stress / UPR (PERK–CHOP)	↑ strong, early activation	↑ moderate, delayed activation	↓ ER stress via antioxidant capacity
DNA damage response	↑ oxidative DNA lesions (ATM/ATR)	↑ low–moderate, secondary to ROS	↓ DNA damage; improved repair environment
PI3K–AKT survival signaling	↓ secondary to oxidative collapse	↓ reported in multiple tumor models	↔ or ↑ survival signaling
NF-κB / inflammatory signaling	↓ via redox inhibition	↓ selectively; anti-inflammatory bias	↓ chronic inflammation (protective)
Ferroptosis involvement	Minor / indirect	↑ lipid peroxidation; GPX4 modulation	↓↓ ferroptosis risk (GPX4 support)
Autophagy	↑ early (protective) → collapse	↑ contributory to tumor suppression	↔ homeostatic maintenance
Angiogenesis (VEGF)	↓ at cytotoxic doses	↓ at lower, tolerated doses	↔ or mild ↓ (indirect)
Immune compatibility	Poor at anticancer doses	Moderate–good; often immune-supportive	High; supports immune competence
Pharmacologic control	Poor (steep dose–toxicity curve)	High (size, coating, release tunable)	Low (slow turnover, storage form)
Normal tissue tolerance	Low	Moderate–high	High
Overall cancer relevance	Potent but hazardous cytotoxic agent	Balanced anticancer redox modulator	Generally counterproductive for direct cancer killing
Overall therapeutic profile	Potent but narrow safety margin	Lower acute potency, broader usable window

Risk, Risk: Click to Expand ⟱

Source:

Type:

Risk: by definition reduces risk of disease or cancer.
Down Target direction of risk indicates lower cancer risk.
ChemoPreventive also mean lower cancer risk. But for Chemopreventive an up arrow indicates more preventive.

Cancer Risk Impact Score (CRIS)
CRIS scale:
–5 = very strong risk reduction
–4 = strong risk reduction
–3 = moderate risk reduction
–2 = modest risk reduction
–1 = weak / context-dependent
0 = neutral


CRIS  Exposure / Compound  Evidence  Cancers  Notes


-5  Exercise (overall)
VStrong Hum  BC, CRC, Endo, PCa, Liv
↓insulin/IGF-1, ↓inflammation, ↑immune surveillance, ↓hormones



-5  Aerobic + resistance  VStrong Hum  Broad inc + mort
Best overall exercise synergy



-4  Aerobic exercise (mod–vig)  VStrong Hum  BC, CRC, Endo
Dose–response; ↓visceral fat



-4  Resistance training (alone)  Strong Hum  BC, CRC
↑insulin sensitivity; ↑lean mass



-3  High-intensity interval training  Mod–Strong Hum  BC, CRC
↑AMPK; ↑mitochondrial function; adherence matters



-2  NEAT / low-intensity activity  Moderate Hum  CRC
↓sedentary harm



-5  Cruciferous vegetable pattern  Strong Hum  Lung, CRC, BC, PCa
↑NRF2, ↓CYP1; ITC synergy



-5  Sunlight exposure (physiologic)  Strong Hum  CRC, BC, PCa
↑circadian alignment, ↑immune effects beyond vitamin D



-4  Fasting (metabolic pattern)
Strong Mech + Hum  BC, CRC, PCa 
↓IGF-1, ↓mTOR, ↑autophagy



-4  Curcumin
Hum + Pre  GI, BC, PCa
↓NF-κB, ↓STAT3



-4  Sulforaphane
Hum + Pre  Lung, CRC, BC
↑NRF2, ↓HDAC



-4  PEITC
Hum + Pre  Lung, CRC, PCa
↓CYP1A2, ↑apoptosis



-4  EGCG (tea matrix)
Strong Hum  GI, PCa, BC
↓angiogenesis; tea matrix superior to extract



-4  Lycopene
Strong Hum  PCa
↓oxidative DNA damage



-4  Apigenin
Pre + Diet Hum  BC, PCa, CRC 
↓PI3K-AKT, ↑p53



-4  Luteolin
Pre + Diet Hum  Lung, CRC, BC 
↓STAT3, ↓EMT



-4  Kaempferol
Diet Hum  Ov, Panc, Lung
↓VEGF, ↑apoptosis



-4  Fisetin
Pre + Early Hum  CRC, PCa, Mel
↓mTOR; senolytic activity



-4  Ellagic acid → Urolithin A
Hum (microbiome)  CRC, PCa, BC
↑mitophagy, ↓ER/AR signaling



-3  Omega-3 (EPA/DHA)
Strong Hum  CRC, BC
↓inflammation, ↓COX-2



-3  Vitamin D3 (supp)
Obs + RCT  CRC, BC
U-shaped response; ↓proliferation



-3  Garlic (allicin)
Mod Hum  GI
↓inflammation, ↓H. pylori



-3  Mushroom beta-glucans
Hum adjunct  GI, BC
↑NK cells, ↑immune surveillance



-3  Melatonin
Hum + Mech  BC, PCa
↓estrogen signaling, ↑circadian regulation



-3  Coffee (whole)
Strong Hum  Liv, Endo
↓fibrosis, ↓inflammation



-2  Quercetin
Limited Hum  Lung, CRC
Senolytic; ↓PI3K signaling



-2  Resveratrol
Limited Hum  CRC, BC
↓NF-κB; low bioavailability



-2  I3C / DIM
Mod Hum  BC, Cerv
↑2-OH estrogen, ↓ER signaling



-2  Thymoquinone
Early Hum  BC, CRC
↑apoptosis, ↓NF-κB



-2  Beta-carotene (food)
Hum  Lung
Antioxidant only in whole-food context



-1  Vitamin K2 (MK-4/7)
Limited Hum  Liv, PCa
↓proliferation, ↑differentiation



-1  Boron
Obs  PCa, Lung
↓inflammation; hormone modulation



0  Vitamin C (oral)
Strong Hum  —
Neutral overall effect



0  Genistein (soy)
Strong Hum  BC, PCa
Timing-dependent effects



0  Selenium (diet)
Mixed Hum  PCa
Narrow therapeutic window



0  Capsaicin
Mixed  Gastric
Dose-dependent effects



+2  Vitamin E (alpha only)
Strong RCT  PCa
Increased risk signal



+2  Green tea extract (high-dose)
Case reports  Liv
Hepatotoxicity reported



+4  Beta-carotene (supplement)
Strong RCT  Lung (smokers)
Increased lung cancer risk in smokers



+5  Alcohol (ethanol)
Strong Hum  BC, Liv, Eso
Linear increase in cancer risk




Evidence
Hum        human data
VStrong    very strong
Strong     strong
Mod        moderate
Obs        observational
Pre        preclinical
RCT        randomized controlled trial
Mech       mechanistic
Adjunct    adjunct clinical use

Scientific Papers found: Click to Expand⟱

4753-

SSE,

Chemo,

Selenium and Lung Cancer: A Systematic Review and Meta Analysis

Review,

Lung,

Risk⇅, chemoP↑, radioP↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Functional Outcomes ⓘ

chemoP↑, 1, radioP↑, 1, Risk⇅, 1,
Total Targets: 3

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: Risk, Risk

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:148  Target#:785  State#:%  Dir#:3
  wNotes=0  sortOrder:rid,rpid

Selenite (Sodium) / Risk Cancer Research Results

Pathway results for Effect on Cancer / Diseased Cells:

Functional Outcomes ⓘ

Pathway results for Effect on Normal Cells:

Home Page